Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Advanced interstitial lung fibrosis with emphysema and pulmonary hypertension with no evidence for interstitial lung disease on high resolution CT.

Foris V, Brcic L, Douschan P, Kovacs G, Stacher-Priehse E, Olschewski H.

Pulm Circ. 2019 Jul-Sep;9(3):2045894019832214. doi: 10.1177/2045894019832214.

2.

Imatinib for right heart failure in COPD.

Douschan P, Kovacs G, Foris V, Kuehnelt-Leddihn M, Olschewski H.

Pulm Circ. 2019 Jan-Mar;9(1):2045894018816974. doi: 10.1177/2045894018816974. Epub 2018 Nov 15.

3.

Biomarkers for Pulmonary Vascular Remodeling in Systemic Sclerosis: A Pathophysiological Approach.

Odler B, Foris V, Gungl A, Müller V, Hassoun PM, Kwapiszewska G, Olschewski H, Kovacs G.

Front Physiol. 2018 Jun 19;9:587. doi: 10.3389/fphys.2018.00587. eCollection 2018. Review.

4.

The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension.

Marsh LM, Jandl K, Grünig G, Foris V, Bashir M, Ghanim B, Klepetko W, Olschewski H, Olschewski A, Kwapiszewska G.

Eur Respir J. 2018 Jan 25;51(1). pii: 1701214. doi: 10.1183/13993003.01214-2017. Print 2018 Jan.

5.

Mild Elevation of Pulmonary Arterial Pressure as a Predictor of Mortality.

Douschan P, Kovacs G, Avian A, Foris V, Gruber F, Olschewski A, Olschewski H.

Am J Respir Crit Care Med. 2018 Feb 15;197(4):509-516. doi: 10.1164/rccm.201706-1215OC.

PMID:
29099619
6.

Changes in pulmonary exercise haemodynamics in scleroderma: a 4-year prospective study.

Kovacs G, Avian A, Wutte N, Hafner F, Moazedi-Fürst F, Kielhauser S, Aberer E, Brodmann M, Graninger W, Foris V, Olschewski A, Olschewski H.

Eur Respir J. 2017 Jul 13;50(1). pii: 1601708. doi: 10.1183/13993003.01708-2016. Print 2017 Jul.

7.

Importance of kynurenine in pulmonary hypertension.

Nagy BM, Nagaraj C, Meinitzer A, Sharma N, Papp R, Foris V, Ghanim B, Kwapiszewska G, Kovacs G, Klepetko W, Pieber TR, Mangge H, Olschewski H, Olschewski A.

Am J Physiol Lung Cell Mol Physiol. 2017 Nov 1;313(5):L741-L751. doi: 10.1152/ajplung.00517.2016. Epub 2017 Jul 13.

8.

Use of ECG and Other Simple Non-Invasive Tools to Assess Pulmonary Hypertension.

Kovacs G, Avian A, Foris V, Tscherner M, Kqiku X, Douschan P, Bachmaier G, Olschewski A, Matucci-Cerinic M, Olschewski H.

PLoS One. 2016 Dec 28;11(12):e0168706. doi: 10.1371/journal.pone.0168706. eCollection 2016.

9.

CD133+ cells in pulmonary arterial hypertension.

Foris V, Kovacs G, Marsh LM, Bálint Z, Tötsch M, Avian A, Douschan P, Ghanim B, Klepetko W, Olschewski A, Olschewski H.

Eur Respir J. 2016 Aug;48(2):459-69. doi: 10.1183/13993003.01523-2015. Epub 2016 Apr 21.

10.

Characterization of patients with borderline pulmonary arterial pressure.

Kovacs G, Avian A, Tscherner M, Foris V, Bachmaier G, Olschewski A, Olschewski H.

Chest. 2014 Dec;146(6):1486-1493. doi: 10.1378/chest.14-0194.

PMID:
25451346
11.

Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients.

Zabini D, Heinemann A, Foris V, Nagaraj C, Nierlich P, Bálint Z, Kwapiszewska G, Lang IM, Klepetko W, Olschewski H, Olschewski A.

Eur Respir J. 2014 Oct;44(4):951-62. doi: 10.1183/09031936.00145013. Epub 2014 Jul 17.

12.

PL-7 positive antisynthetase syndrome and pulmonary hypertension.

Foris V, Kovacs G, Matucci-Cerinic M, Olschewski H.

J Rheumatol. 2013 Oct;40(10):1777-9. doi: 10.3899/jrheum.130403. No abstract available.

PMID:
24085762
13.

Biomarkers in pulmonary hypertension: what do we know?

Foris V, Kovacs G, Tscherner M, Olschewski A, Olschewski H.

Chest. 2013 Jul;144(1):274-283. doi: 10.1378/chest.12-1246. Review.

PMID:
23880678
14.

Mesenchymal stem cell irradiation in culture engages differential effect of hyper-fractionated radiotherapy for head and neck cancers.

Tomuleasa C, Soritau O, Brie I, Pall E, Foris V, Dicu T, Virag P, Irimie A, Kacso G.

J BUON. 2010 Apr-Jun;15(2):348-56.

15.

Enhanced chemoresistance and tumor sphere formation as a laboratory model for peritoneal micrometastasis in epithelial ovarian cancer.

Soriţău O, Tomuleasa CI, Páll E, Virág P, Fischer-Fodor E, Foris V, Barbos O, Tatomir C, Kacsó G, Irimie A.

Rom J Morphol Embryol. 2010;51(2):259-64.

16.

Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma.

Tomuleasa C, Soritau O, Rus-Ciuca D, Pop T, Todea D, Mosteanu O, Pintea B, Foris V, Susman S, Kacsó G, Irimie A.

J Gastrointestin Liver Dis. 2010 Mar;19(1):61-7.

17.

Effects of 60Co gamma-rays on human osteoprogenitor cells.

Tomuleasa CI, Foris V, Soriţău O, Páll E, Fischer-Fodor E, Lung-Illes V, Brie I, Virág P, Perde-Schrepler M, Postescu ID, Cherecheş G, Barbos O, Tatomir C.

Rom J Morphol Embryol. 2009;50(3):349-55.

Supplemental Content

Support Center